Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-096512

CEO & President sold 2,732 shares at $14.90 ($40,707)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cox John · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-05 Sale : show line 1 in the form 10b5-1 −2,732 $14.90 $40,707 374,145 D
Open-market sales · 2,732 sh · avg $14.90 · $40,707
Loading xslF345X05/ownership.xml…